Drug information provided by: Merative, Micromedex®
Elotuzumab injection is used together with lenalidomide and dexamethasone to treat multiple myeloma (a blood cell cancer) in patients who have received one to three previous cancer treatments. It is also used together with pomalidomide and dexamethasone to treat multiple myeloma in patients who have received at least two previous cancer treatments (eg, lenalidomide, proteasome inhibitor). Elotuzumab interferes with the growth of cancer cells, which are then destroyed by the body. It is an antineoplastic agent (cancer medicine).
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
Portions of this document last updated: Feb. 01, 2024
Copyright: © Merative US L.P. 1973, 2024. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Thanks to generous benefactors, your gift today can have 5X the impact to advance AI innovation at Mayo Clinic.